Accendra Health (ACH) Free Cash Flow Growth (3y) (2012 - 2026)
Accendra Health (ACH) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 0.80% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 30.60% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 10.23% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -212.44% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -45.61% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -3.17% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -22.47% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 44.68% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.61% |
| Dec 31, 2025 | 72.00% |
| Sep 30, 2025 | -67.75% |
| Jun 30, 2025 | 35.98% |
| Mar 31, 2025 | -44.74% |
| Dec 31, 2024 | 0.64% |
| Sep 30, 2024 | -35.93% |
| Jun 30, 2024 | 64.21% |
| Mar 31, 2024 | -68.30% |
| Dec 31, 2023 | -1.64% |
| Sep 30, 2023 | -36.74% |
| Jun 30, 2023 | 86.02% |
| Mar 31, 2023 | 6.66% |
| Dec 31, 2022 | -49.60% |
| Sep 30, 2022 | 14.42% |
| Jun 30, 2022 | -33.20% |
| Mar 31, 2022 | 45.49% |
| Dec 31, 2021 | 78.65% |
| Sep 30, 2021 | -6.12% |
| Jun 30, 2021 | -35.43% |